BCG Vaccines Sales Market Outlook and Opportunities in Grooming Regions
                     BCG Vaccines Sales Market to Worth $65 
Million by 2026 | By Product, Business & 
Application
BCG Vaccines Sales Market by Drug Type (Immune BCG and Therapy BCG), Usage (Tuberculosis and Bladder Cancer), and 
End User (Pediatrics and Adults): Opportunity Analysis and Industry Forecast, 2018 - 2025
Why Allied Market Research?
FREQUENTLY ASKED QUESTIONS?
INFALLIBLE METHODOLOGY
To ensure high-level data integrity, accurate analysis, and Q1. What is the total market value of 
impeccable forecasts
BCG vaccines sales market report?
ANALYST SUPPORT
Q2. What would be forecast period in 
For complete satisfaction the market report?
CUSTOMIZATION Q3. What is the market value of BCG 
On-demand customization of scope of the report to exactly meet vaccines sales market in 2020?
your needs
Q4. Which is base year calculated in 
TARGETED MARKET VIEW the BCG vaccines sales market report?
Targeted market view to provide pertinent information and save Q5. Which are the top companies hold 
time of readers the market share in BCG vaccines sales 
market?
Overview
According to a new report published by Allied Market 
Research, titled, "Global BCG Vaccines Sales Market by 
Drug Type, Usage, End User, Region: Global Opportunity 
Analysis and Industry Forecast, 2018 - 2025,"the Global BCG 
vaccines sales market size is expected to increase and is 
anticipated to reach $65 million by 2025, registering a CAGR 
of 4.2% from 2019 to 2025.
BCG vaccine is a live attenuated vaccine used for the 
prevention of tuberculosis. The types of BCG drugs include 
immune BCG and therapy BCG. The BCG vaccines sales 
market growth has increased owing to gained prominence in 
the recent years due to high prevalence of tuberculosis 
worldwide and rise in number of drug-resistant tuberculosis 
cases. However, replacement for BCG vaccine is expected to 
restrain the market growth.
Segments
In terms of revenue, the global surgical robotics market is 
segmented on the basis of Drug Type, Usage and End User. 
By Drug Type- Depending on drug type, the immune BCG 
segment is the highest revenue contributor and is also expected 
to exhibit the fastest growth rate of 4.9%. This is attributed to 
the wider use of BCG vaccine to acquire immunity against 
tuberculosis and absence of substitute to BCG vaccines currently.
By Usage- Based on usage, the tuberculosis segment occupied 
the largest share of the market in 2017 and is expected to grow 
at the highest rate during the forecast period. Factors such as 
high prevalence of tuberculosis and large number of deaths due 
to tuberculosis globally significantly contribute toward the 
growth of this segment.
Geography
North America dominated the BCG vaccines sales 
market. The market growth in North America is 
primarily a reflection of product innovations and 
launches resulting from technological advancements. 
The companies mostly adopted product launch, 
acquisition, and expansion as their key strategies to 
keep pace with the changing demands of consumers 
and strengthen their market position.
Key Market Players
The key players operating in the global BCG vaccines sales market are 
• AJ Vaccines, 
• China National Pharmaceutical Group Corporation (Sinopharm), 
• Greensignal Bio Pharma Limited, Intervax Ltd,
• Japan BCG Laboratory, 
• Merck & Company Inc, 
• Sanofi S.A., 
• Serum Institute of India Pvt. Ltd., 
• Statens Serum Institute.
• An in-depth market analysis includes analysis of various 
regions, which is anticipated to provide a detailed 
Key Findings of the understanding of the current trends to enable 
stakeholders formulate region-specific plans.
BCG vaccines sales • A comprehensive analysis of factors that drive and 
market: restrain the growth of the global is provided.
• The projections in this report are made by analyzing the 
current trends and future market potential from 2021 to 
2030, in terms of value.
Find out more at the Allied Market Report store
https://www.alliedmarketresearch.com/bcg-vaccine-sales-market
ABOUT ALLIED MARKET RESEARCH
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in 
Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched 
quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business 
insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their 
respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us 
generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented 
in the reports published by us is extracted through primary interviews with top officials from leading companies of domain 
concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with 
knowledgeable professionals and analysts in the industry.
Contact:  
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com